Cargando…
Single-shot AAV-vectored vaccine against SARS-CoV-2 with fast and long-lasting immunity
Due to the insufficient long-term protection and significant efficacy reduction to new variants of current COVID-19 vaccines, the epidemic prevention and control are still challenging. Here, we employ a capsid and antigen structure engineering (CASE) strategy to manufacture an adeno-associated viral...
Autores principales: | Wu, Fuhua, Luo, Shuang, Zhang, Yongshun, Ou, Yangsen, Wang, Hairui, Guo, Zhaofei, He, Chunting, Bai, Shuting, He, Penghui, Jiang, Min, Chen, Xiaoyan, Du, Guangsheng, Sun, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273293/ https://www.ncbi.nlm.nih.gov/pubmed/35846427 http://dx.doi.org/10.1016/j.apsb.2022.07.004 |
Ejemplares similares
-
Nanoparticles with rough surface improve the therapeutic effect of photothermal immunotherapy against melanoma
por: Xue, Jiao, et al.
Publicado: (2022) -
Recent advances in respiratory immunization: A focus on COVID-19 vaccines
por: He, Xiyue, et al.
Publicado: (2023) -
T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021) -
AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018) -
Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2016)